Centennial Wealth Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Centennial Wealth Advisory's PFE Position: Q3 2026 in Review
Centennial Wealth Advisory increased its Pfizer (PFE) stake by 3.8% in Q3 2026, buying an estimated $47.9K and bringing the position to 49,557 shares worth $1.41M. The position accounts for 0.29% of the portfolio, ranked #47.
Centennial Wealth Advisory first reported a position in PFE in Q2 2022 and has held it in 15 quarters since. 648 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Centennial Wealth Advisory held 49,557 shares of Pfizer worth $1.41M as of Q3 2026.
- Centennial Wealth Advisory bought 1,800 Pfizer shares in Q3 2026, an estimated $47.9K.
- Pfizer made up 0.29% of Centennial Wealth Advisory's portfolio in Q3 2026, its #47 holding.
- Centennial Wealth Advisory first reported a position in Pfizer in Q2 2022 and has held it in 15 quarters since.
- 648 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Centennial Wealth Advisory's 13F filing for Q3 2026, filed 16 Oct 2026.